Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

ChiCTR-ONC17011792 - Fecal Microbiota Transplantation (FMT) & Type 2 diabetes (T2D)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

Background

There is growing evidence indicating that changes in the gut microbiota play a role in the development of type 2 diabetes. Fecal microbiota transplantation has been effective in treating various human diseases. Despite this, the advantages of FMT therapy for patients with type 2 diabetes mellitus are still unclear (1).

Study overview

ChiCTR-ONC17011792 - Fecal Microbiota Transplantation (FMT) & Type 2 diabetes (T2D) is a non-blinded clinical trial studying Fecal Microbiota Transplantation in 17 evaluable patients with Type 2 diabetes (1)

Outcome measures

HbA1c and metabolic parameter change 12 weeks afte…

References (Sources)

Prospective Study Reveals Host Microbial Determinants of Clinical Response to Fecal Microbiota Transplant Therapy in Type 2 Diabetes Patients
Ding et al. 2022 Front Cell Infect Microbiol 12: 820367

AI Chat

7/1/2026

Chat with our artificial intelligence:

Start chat!